Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 6Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Waldenstrom Macroglobulinemia 1Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Immunoblastic Lymphadenopathy 1Burkitt Lymphoma 1

Interventions

Vincristine 2Prednisone 2Gemcitabine 2Cyclophosphamide 2liposomal amphotericin B 1ixabepilone 1imetelstat 1Watchful Waiting 1VAP-cyclo protocol 1Rituximab 1Radiotherapy 1Palliative Care 1Nutritional Support 1Nicotine 1Moxifloxacin 1Morphine 1Lapatinib 1Everolimus 1Doxorubicin 1Dextromethorphan 1Dexamethasone 1Cytarabine 1Cyclosporins 1Cyclosporine 1Cisplatin 1Ciprofloxacin 1Celecoxib 1Caspofungin 1Analgesia 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Immunoblastic Lymphadenopathy × VAP-cyclo protocol × Clear all
NCT00079261 2012-09-24

Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
25 enrolled
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡